{"filing":{"accession_number":"0001628280-26-052152","cik":"0001779128","ticker":"SRTA","company_name":"Strata Critical Medical, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"srta-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/srta-20260804.htm"},"events":[{"id":24021,"run_id":21728,"accession_number":"0001628280-26-052152","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed under Item 2.02 \"Results of Operations and Financial Condition.\" The press release discloses comprehensive GAAP and non-GAAP financial results including revenue of $72.5 million (60.7% YoY growth), net loss from continuing operations of $(10.5) million, Adjusted EBITDA of $7.9 million, and updated 2026 full-year guidance. The filing explicitly states the press release is \"furnished as Exhibit 99.1\" and is \"incorporated by reference herein,\" which is the standard format for earnings releases on Form 8-K.","company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24405,"accession_number":"0001628280-26-052152","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed under Item 2.02 \"Results of Operations and Financial Condition.\" The press release discloses comprehensive GAAP and non-GAAP financial results including revenue of $72.5 million (60.7% YoY growth), net loss from continuing operations of $(10.5) million, Adjusted EBITDA of $7.9 million, and updated 2026 full-year guidance. The filing explicitly states the press release is \"furnished as Exhibit 99.1\" and is \"incorporated by reference herein,\" which is the standard format for earnings releases on Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:39:16.718643+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24405,"accession_number":"0001628280-26-052152","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, filed under Item 2.02 \"Results of Operations and Financial Condition.\" The press release discloses comprehensive GAAP and non-GAAP financial results including revenue of $72.5 million (60.7% YoY growth), net loss from continuing operations of $(10.5) million, Adjusted EBITDA of $7.9 million, and updated 2026 full-year guidance. The filing explicitly states the press release is \"furnished as Exhibit 99.1\" and is \"incorporated by reference herein,\" which is the standard format for earnings releases on Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:39:16.718643+00:00","company_name":"Strata Critical Medical, Inc.","ticker":"SRTA","filing_date":"2026-08-04"}]}